Strengthening its myopia-management portfolio, CooperVision’s new soft contact lens, MyDay MiSight 1 day, is now available to wearers in New Zealand and Australia.
Combining the proven ActivControl Technology of MiSight 1 day with the advanced silicone hydrogel material used in MyDay lenses, the lens provides the same clear vision and myopia-control benefits as the MiSight 1 day design but now with excellent comfort, enhanced ease of handling and breathability, said the company.
“CooperVision has spent over a decade building expertise in myopia management across more than 40 countries,” said Michelle North, general manager CooperVision ANZ. “MyDay MiSight 1 day brings together our most advanced contact lens material with an optical design already trusted by hundreds of thousands of parents and children worldwide.”
In clinical studies and research spanning 10 years, the ActivControl Technology used in both MiSight 1 day and MyDay MiSight 1 day has been found to slow myopia progression similar to levels seen in emmetropic eyes, when worn as prescribed, said CooperVision. Importantly, the myopia-control benefits from ActivControl Technology in MyDay MiSight 1 day were retained after treatment ended, it added.
The silicone hydrogel material in the new MyDay MiSight 1 day lens provides up to four times the oxygen transmissibility compared with traditional hydrogel lenses and supports sustained comfort throughout the day, CooperVision said. “In clinical evaluations involving children, MyDay MiSight 1 day demonstrated high levels of wearability, including 100% fitting success, excellent handleability and visual acuity measuring better than 6/6.”
